Financial Ratios

DISHMAN PHARMACEUTICALS & CHEMICALS LTD. - (AMALGAMATED)

NSE : NABSE : 532526ISIN CODE : INE353G01020Industry : Pharmaceuticals & DrugsHouse : Dishman Pharma
BSE301.050 (0 %)
PREV CLOSE ( ) 301.05
OPEN PRICE ( ) 293.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 301.05 (1375)
VOLUME 460499
TODAY'S LOW / HIGH ( )278.10 304.30
52 WK LOW / HIGH ( ) 278.1304.3
NSE
This Company is not listed in NSE
Select year
ParticularsMar2016Mar2015Mar2014Mar2013Mar2012
Operational & Financial Ratios
   Earnings Per Share (Rs)10.807.2510.757.835.56
   CEPS(Rs)8.146.368.116.104.74
   DPS(Rs)2.002.001.201.201.20
   Book NAV/Share(Rs)112.74103.4498.5789.6883.26
   Tax Rate(%)27.5343.6726.9733.2933.60
Margin Ratios
   Core EBITDA Margin(%)33.0929.8136.8134.5130.89
   EBIT Margin(%)36.6134.6039.2830.0826.66
   Pre Tax Margin(%)23.3020.8924.8219.3214.40
   PAT Margin (%)16.8911.7718.1312.899.56
   Cash Profit Margin (%)25.4620.6527.3520.1016.31
Performance Ratios
   ROA(%)4.723.475.684.303.07
   ROE(%)9.997.1711.439.056.84
   ROCE(%)12.5712.3514.6512.2510.59
   Asset Turnover(x)0.280.290.310.330.32
   Sales/Fixed Asset(x)0.520.520.520.640.74
   Working Capital/Sales(x)2.2137.48-26.6421.79-10.07
Efficiency Ratios
   Fixed Capital/Sales(x)1.931.941.911.561.35
   Receivable days65.6161.3550.4059.2986.94
   Inventory Days112.21112.2799.7391.9294.70
   Payable days164.85156.36185.79183.51190.64
Valuation Parameters
   PER(x)15.5511.523.894.414.13
   PCE(x)20.6313.135.155.664.84
   Price/Book(x)2.981.610.850.770.55
   Yield(%)0.601.201.441.742.62
   EV/Net Sales(x)6.533.972.512.211.84
   EV/Core EBITDA(x)14.299.055.125.855.44
   EV/EBIT(x)17.6311.376.327.256.82
   EV/CE(x)1.781.080.760.710.59
   M Cap / Sales5.312.741.431.150.80
Growth Ratio
   Net Sales Growth(%)3.694.00-2.344.5810.12
   Core EBITDA Growth(%)7.90-6.9427.0316.6233.87
   EBIT Growth(%)9.86-8.5627.5517.8940.41
   PAT Growth(%)49.03-32.6237.3740.9011.74
   EPS Growth(%)49.03-32.6237.3740.9011.74
Financial Stability Ratios
   Total Debt/Equity(x)0.690.760.660.720.73
   Current Ratio(x)1.531.030.961.060.88
   Quick Ratio(x)1.200.700.660.740.57
   Interest Cover(x)2.752.522.722.802.17
   Total Debt/Mcap(x)0.230.470.780.941.32

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.